Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-08-19 to 2024-08-20
Current total value of award: $27685.77
Description: 4565504753!ADBRY 150 MG/ML SYRINGEML